InvestorsHub Logo
icon url

kipster210

06/03/13 9:41 AM

#30959 RE: Whosetosay #30957

CLVS does not have a great history......watch for hedge funds to short this stock.

November 12, 2012
Among actively traded Colorado-based stocks that declined on the day was Clovis Oncology Inc. (CLVS), down $41.83 percent ($8.99) to close at $12.50.
The Boulder biotech disclosed Monday that a pancreatic drug it hoped would lengthen the lives of patients failed to show significant effects among patients in tests.
icon url

piece o mind

06/03/13 9:43 AM

#30962 RE: Whosetosay #30957

It seems like this is always the case. an event takes place that everyone seems to be waiting on for results. only to listen to people say till the next event once that event has concluded. because of non movement in price or a steep drop. DeJA F**king Vu!
icon url

oldchemist4

06/03/13 9:59 AM

#30971 RE: Whosetosay #30957

Yes, but this is biotech investing. CLVS has 1/8th the float of ARIA, and daily volume about 1/3rd of ARIA, so there is a simple magnification to consider.

More rationally - if that is the right word - ARIA has a product on the market with sales numbers that can be used to drive any particular discussion. CLVS has 3 drug candidates - and no product sales to confuse anyone's predictions.

Still, they got what the wanted/needed, and I wish them well !